对败血症相关脑病的神经保护剂的探索:综合性审查
Klaudia Krzyzaniak1, Robert Krion1, Aleksandra Szymczyk1
1Department of Emergency Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.
International journal of molecular sciences
|July 14, 2023
概括
败血症相关脑病变 (SAE) 是败血症的一个大脑并发症. 本综述总结了可能治疗SAE的神经保护物质及其长期认知影响.
科学领域:
- 神经科学是一个神经科学.
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 败血症是对感染的危及生命的炎症反应,通常会导致多器官衰竭.
- 败血症相关脑病变 (SAE) 是一个频繁的并发症,呈现急性认知和意识障碍.
- 正确的SAE机制,包括神经炎症和血脑屏障破坏,仍在调查中.
研究的目的:
- 综合审查具有治疗SAE的神经保护潜力的物质.
- 探索SAE的治疗选择,解决其复杂的病理生理学.
- 为了确定可以减轻毒症急性和长期神经系统后果的药物.
主要方法:
- 进行了广泛的文献搜索,以确定相关的研究.
- 从专注于神经保护剂的71篇文章中提取了数据.
- 分类物质包括植物药物,和抗体.
主要成果:
- 确定了各种具有已证明或潜在神经保护性质的物质.
- 突出了SAE研究的多种治疗剂的多样性.
- 综合了关于不同神经保护策略的机制和有效性的信息.
结论:
- 神经保护性物质在管理SAE及其后续方面表现有前途.
- 对这些药物的进一步研究可能会导致SAE的新型治疗策略.
- 本综述为临床医生和研究人员在败血症和SAE管理方面提供了宝贵的见解.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
349
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
349
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Antiepileptic Drugs: Glutamate Antagonists
427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427
Anticholinesterase Agents: Poisoning and Treatment
923
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
923
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
159
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
159


